Let's be correct, there was no share buyback. It was announced they "may" buy back shares with free cash at the proper level, but unfortunately it was a bunch of smoke. Now there is no free cash but plenty of upside for increasing revenue and share price. BRAV is undervalued, no doubt. However CEO Danny needs to get out of the rut the company fell into following many great profitable quarters and a bad shift in focus to Viva Vuva. Muscle Flex is a good opportunity, I really would like to see this pan out well.
News 
Market Data 
Discover 
